Applied Short Long Term Debt from 2010 to 2024

APLT Stock

USD 2.03 6.54 76.31%

Applied Therapeutics Short and Long Term Debt yearly trend continues to be comparatively stable with very little volatility. Short and Long Term Debt is likely to outpace its year average in 2024. Short and Long Term Debt is the total of a company's short-term and long-term borrowings. View All Fundamentals

Short and Long Term Debt

First Reported

2010-12-31

Previous Quarter

310 K

Current Value

512.4 K

Quarterly Volatility

413.6 K

Credit Downgrade

Yuan Drop

Covid

Check Applied Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Applied Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 1.4 M, Interest Income of 1.1 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 22.59, Dividend Yield of 0.0 or Days Sales Outstanding of 8.33. Applied financial statements analysis is a perfect complement when working with Applied Therapeutics Valuation or Volatility modules.

Check out the analysis of Applied Therapeutics Correlation against competitors.

For more information on how to buy Applied Stock please use our How to Invest in Applied Therapeutics guide.

Latest Applied Therapeutics' Short Long Term Debt Growth Pattern

Below is the plot of the Short Long Term Debt of Applied Therapeutics over the last few years. It is the total of a company's short-term and long-term borrowings. Applied Therapeutics' Short and Long Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Applied Therapeutics' overall financial position and show how it may be relating to other accounts over time.

Short Long Term Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Short Long Term Debt

Timeline

Applied Short Long Term Debt Regression Statistics

	Arithmetic Mean	292,094
	Geometric Mean	0.00
	Coefficient Of Variation	141.61
	Mean Deviation	350,513
	Median	0.00
	Standard Deviation	413,629
	Sample Variance	171.1B
	Range	1.1M
	R-Value	0.66
	Mean Square Error	104.1B
	R-Squared	0.44
	Significance	0.01
	Slope	61,010
	Total Sum of Squares	2.4T

Applied Short Long Term Debt History

	2024	512.4 K
	2023	310 K
	2022	622 K
	2021	789 K
	2019	1.1 M

Other Fundumenentals of Applied Therapeutics

Short Long Term Debt Total

Applied Therapeutics Short Long Term Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Capital Surpluse	Total Liab	Net Invested Capital	Total Current Assets	Net Working Capital	Current Deferred Revenue	Net Receivables
Total Assets		0.75	0.89	-0.94	-0.66	0.52	0.86	0.56	0.76	1.0	0.7	0.61	-0.27
Total Stockholder Equity	0.75		0.42	-0.55	-0.03	0.51	0.35	-0.12	1.0	0.75	0.99	0.91	0.35
Net Tangible Assets	0.89	0.42		-0.88	-0.88	0.38	0.98	0.81	0.43	0.89	0.35	0.27	-0.63
Net Debt	-0.94	-0.55	-0.88		0.78	-0.37	-0.9	-0.73	-0.55	-0.94	-0.48	-0.45	0.4
Retained Earnings	-0.66	-0.03	-0.88	0.78		-0.3	-0.94	-0.96	-0.04	-0.67	0.05	0.12	0.86
Accounts Payable	0.52	0.51	0.38	-0.37	-0.3		0.4	0.14	0.51	0.52	0.46	0.22	-0.02
Capital Surpluse	0.86	0.35	0.98	-0.9	-0.94	0.4		0.86	0.35	0.86	0.27	0.18	-0.7
Total Liab	0.56	-0.12	0.81	-0.73	-0.96	0.14	0.86		-0.11	0.56	-0.2	-0.23	-0.84
Net Invested Capital	0.76	1.0	0.43	-0.55	-0.04	0.51	0.35	-0.11		0.76	0.99	0.91	0.34
Total Current Assets	1.0	0.75	0.89	-0.94	-0.67	0.52	0.86	0.56	0.76		0.69	0.61	-0.27
Net Working Capital	0.7	0.99	0.35	-0.48	0.05	0.46	0.27	-0.2	0.99	0.69		0.94	0.43
Current Deferred Revenue	0.61	0.91	0.27	-0.45	0.12	0.22	0.18	-0.23	0.91	0.61	0.94		0.52
Net Receivables	-0.27	0.35	-0.63	0.4	0.86	-0.02	-0.7	-0.84	0.34	-0.27	0.43	0.52

Click cells to compare fundamentals

About Applied Therapeutics Financial Statements

Applied Therapeutics shareholders use historical fundamental indicators, such as Short Long Term Debt, to determine how well the company is positioned to perform in the future. Although Applied Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Applied Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Applied Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Short and Long Term Debt	310 K	512.4 K
Short and Long Term Debt Total	777 K	1.1 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Applied Stock Analysis

When running Applied Therapeutics' price analysis, check to measure Applied Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied Therapeutics is operating at the current time. Most of Applied Therapeutics' value examination focuses on studying past and present price action to predict the probability of Applied Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied Therapeutics' price. Additionally, you may evaluate how the addition of Applied Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC